Fact CheckerSign in

NCT06655636Recruiting

Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors

Assisting Stroke Survivors With Engineering Technology (ASSET): Design Project D3: Exoskeletal Networks for Forearm Supination

Source: ClinicalTrials.gov · Last updated 9 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to evaluate the safety, feasibility, and efficacy of an exoskeletal network of passive, multi-joint springs for forearm supination. Also known as the forearm ExoNET, the device is a passive, robotic device that will properly assist forearm supination in the post-stroke adult population.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
25 Mar 2024
Start date
4 Dec 2024
Primary completion date
Dec 2025
Lead sponsor
Shirley Ryan AbilityLab
Diseases
Stroke
NCT number
NCT06655636

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 4 Dec 2024 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Botox injection to the affected upper extremity within the previous 4 months
  • Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy

Other illness

  • Diffuse/multiple lesion sites or multiple stroke events
  • Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to consent, perform the experiment, or follow commands
  • Meet any of the contraindications to Delsys Trigno Sensors:
    • Implanted with electronic devices of any kind, including cardiac pace-makers or similar assistive devices, electronic induction pumps, and implanted stimulators
    • Irritated skin or open wounds
    • Silver allergy

Other

  • Bilateral paresis
  • Hemispatial neglect or visual field cut that prevent visual feedback
  • Shoulder pain and/or articular rigidity on the upper limb joint
  • Severe sensory deficits indicated by the Two-Point Discrimination Test
  • Other neurological issues

Who the study is looking for

  • Between the ages of 40-70 (to reduce confounding effects of aging on muscle, movement accuracy and proprioception)
  • Have sustained a single, unilateral stroke at least 8 months prior to enrollment
  • Severe to moderate upper extremity impairment (ARAT score 0-30)
  • Ability to move their elbow and wrist when supported against gravity
  • Cortical stroke with hemiparesis, tactile sensation
  • Available medical records about lesion locations indicating the stroke was caused by a middle cerebral artery ischemic infarct

Age in the registry: 40 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shirley Ryan AbilityLab
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.